State Ledger
Company profile

Tempest Therapeutics, Inc. CIK 1544227

Ticker
TPST (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Brisbane, CA 94005
Fiscal year end
2025 (FY)
Market Data
Close
$0.76
Change
-$0.00
Change %
-0.35%
Volume
1,031

TPST · trading date Oct 12, 2026 · previous close $0.76 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$26.26M
Total assets
$16.93M
Total liabilities
$10.26M
Stockholders' equity
$6.67M
Cash & equivalents
$7.71M
Operating income
-$26.58M
Operating cash flow
-$26.82M
Capital expenditures
$0

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$26.82M
Free cash flow margin
—
Liabilities / assets
60.6%
Equity / assets
39.4%
CapEx / revenue
—
Operating cash flow / net income
1.02×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$26.26M $16.93M $10.26M $6.67M
2024 — -$41.84M $41.49M $22.36M $19.13M
2023 — -$29.49M $51.60M $24.84M $26.77M
2022 — -$35.71M $46.09M $27.98M $18.11M
2021 — -$28.30M $73.24M $37.12M $36.12M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-17
Financials filed via
Form 10-K
filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Brisbane, CA 94005
2000 SIERRA POINT PARKWAY
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:17 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies